# Wilson Sonsini Goodrich & Rosati

> Wilson Sonsini Goodrich & Rosati is a VC fund backing Software. See 116 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Palo Alto, United States
- Total investments: 116
- Last investment: Jan 2026
- Lead investor: 4%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company-beta/166944
- X (Twitter): http://twitter.com/wilsonsonsini
- Website: http://www.wsgr.com
- Facebook: http://www.facebook.com/wilsonsonsini

Wilson Sonsini Goodrich & Rosati is a VC fund in Palo Alto focused on Software and Biotechnology. Wilson Sonsini Goodrich & Rosati is the premier legal advisor to technology, life sciences, and other growth enterprises worldwide. They represent companies at every stage of development, from entrepreneurial start-ups to multibillion-dollar global corporations, as well as the venture firms, private equity firms, and investment banks thatfinance and advise them. The firm's broad range of services and practice areas are focused on addressing the principal challenges faced by the management, boards of directors, shareholders, and in-house counsel of their clients.The firm is nationally recognized for providing high-quality services to address the legal solutions required by its enterprise and financial institution clients. Their services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law, among other areas. Their distinguished international roster of clients span a wide variety of industries, including information technology, life sciences, energy and clean technology, media and entertainment, communications, retail, and financial services.

## Contacts

5 contacts available for Wilson Sonsini Goodrich & Rosati. Shizune tracks 17 team members at Wilson Sonsini Goodrich & Rosati. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/wilson-sonsini-goodrich-rosati?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $450k–$7.3M |
| Series A | $1.5M–$15M |
| Series B | $8.5M–$55M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 24 | 21% |
| Biotechnology | 17 | 15% |
| Health Care | 14 | 12% |
| Artificial Intelligence | 14 | 12% |
| Internet | 11 | 9% |

171 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 39 | 34% |
| Series A | 31 | 27% |
| Series B | 15 | 13% |
| Funding Round | 7 | 6% |
| Pre-Seed | 6 | 5% |

12 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 96 | 83% |
| Kenya | 1 | 1% |
| Israel | 1 | 1% |
| Hong Kong | 1 | 1% |
| El Salvador | 1 | 1% |

6 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| David Wanek | Law Clerk | 1 | https://shizune.co/investors/profile/david-wanek |
| Donald E. Bradley | General Counsel | 0 | https://shizune.co/investors/profile/donald-e-bradley |
| Douglas J. Clark | Managing Partner | 0 | https://shizune.co/investors/profile/douglas-j-clark |
| Jeffrey Saper | Vice Chairman | 0 | https://shizune.co/investors/profile/jeffrey-d-saper |
| Jim Jensen | Member/Partner | 0 | https://shizune.co/investors/profile/jim-jensen-4 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| NANOCHON | Nanochon is a biotech and medical device company specializing in the development of innovative orthopedic solutions. The company develops medical implant technology focused on cartilage repair for patients with joint surface damage. Its primary product, Chondrograft, is a 3D-printed, synthetic implant engineered to replace lost or damaged cartilageand support the body’s own tissue repair. The design uses a nylon-based composite with structural properties intended to mimic natural cartilage and fit securely into defects using a press-fit surgical procedure. Nanochon’s solution targets individuals who require more than temporary relief but are not yet candidates for total joint replacement, offering an off-the-shelf device that integrates with the healing process. The company’s work includes advancing clinical evaluation and surgical use of its implant technology. | $4.1M | Seed | Jan 12, 2026 |  |
| Aeovian Pharmaceuticals | Aeovian Pharmaceuticals is a San Francisco Bay Area-based biopharmaceutical company aiming to discover, develop, and commercialize innovative therapeutics for the treatment of rare and age-related diseases. The company is developing compounds to modulate molecular pathways that address the underlying causes of disease initiation and progression,such as oxidative, cellular and environmental stress.Aeovian Pharmaceuticals was founded in 2012. | $55M | Series B | Dec 16, 2025 |  |
| Sober Sidekick | Gamified peer to peer support | $7.6M | Venture - Series Unknown | Dec 03, 2025 |  |
| Iambic | The Iambic AI-driven platform was created to address the most challenging design problems in drug discovery, leveraging technology innovations such as Enchant, a multi-modal transformer model that predicts clinical outcomes from the earliest stages of discovery, and NeuralPLexer, the best-in-class predictor of protein and protein-ligand structures.The integration of physics principles into the platform’s AI architectures improves data efficiency and allows molecular models to venture widely across the space of possible chemical structures. The platform enables identification of novel chemical modalities for engaging difficult-to-address biological targets, discovery of defined product profiles that optimize therapeutic window, and multi-parameter optimization for highly differentiated development candidates. Through close integration of AI-generated molecular designs with automated experimental execution, Iambic completes design-make-test cycles on a weekly cadence. | $127.8M |  | Nov 10, 2025 |  |
| Coral Vita | Coral Vita grows corals to revitalize dying reefs. | $8M | Series A | Jun 06, 2025 |  |
| Neon Mobile | Neon Mobile is an online application that offers to pay customers for their anonymized phone call data. | $1.5M | Pre-Seed | May 27, 2025 |  |
| SingleFile Technologies | SingleFile is an AI-powered compliance platform automating compliance filings and annual reports across 50 states for complex multi-entity organizations. The platform centralizes Secretary of State filings, annual reports, EIN applications, and service-of-process management in a single collaborative workspace designed for organizations managinglarge entity portfolios at scale.SingleFile's technology automates jurisdiction-specific requirements across all 50 states and the District of Columbia, processing thousands of filings in minutes rather than days. Services include entity formations, foreign qualifications, certificates of good standing, amendments, apostilles, and certified document retrieval.The multi-user platform enables seamless collaboration between organizations and their outside counsel or fund administrators, with audit-ready documentation and a pricing model that charges only for services performed—no per-user or per-entity fees. | $9.1M | Series A | Feb 19, 2025 |  |
| General Proximity | General Proximity is a pioneering future-oriented proximity medicine that envisions the future of medicine. | $16M | Seed | Jan 03, 2025 |  |
| nChroma Bio | nChroma Bio's integrated product engine allows for safe, accurate, and targeted in vivo administration, addressing major shortcomings of current genetic medicine techniques. | $75M | Venture - Series Unknown | Dec 11, 2024 |  |
| Yolo Bank | Yolo Bank is a fintech company that uses artificial intelligence to help universities minimize tuition defaults. This approach increases revenue for educational institutions and benefits students. We offer a SaaS for bad debt management and a dedicated digital account for students to manage their monthly payments. | $533.1K | Pre-Seed | Sep 12, 2024 |  |

10 of 116 investments shown.

## Co-investors
- [Fenwick & West](https://shizune.co/investors/profile/fenwick-west) — VC Fund, 6 deals together
- [Khosla Ventures](https://shizune.co/investors/profile/khosla-ventures) — VC Fund, 6 deals together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 5 deals together
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund, 5 deals together
- [Capital Factory](https://shizune.co/investors/profile/capital-factory) — VC Fund, 4 deals together
- [Cooley](https://shizune.co/investors/profile/cooley-llp) — VC Fund, 4 deals together

## Similar investors

### Similar industry
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund
- [British Business Investments](https://shizune.co/investors/profile/british-business-investments) — VC Fund
- [White Star Capital](https://shizune.co/investors/profile/white-star-capital) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Launch Africa](https://shizune.co/investors/profile/launch-africa) — VC Fund
- [Ventures Platform](https://shizune.co/investors/profile/ventures-platform) — VC Fund
- [Women Entrepreneurship for Africa](https://shizune.co/investors/profile/women-entrepreneurship-for-africa) — VC Fund

## Featured in investor lists
- [Travel Investors in United States](https://shizune.co/investors/travel-investors-united-states)
- [Publishing VC Funds in United States](https://shizune.co/investors/publishing-vc-funds-united-states)
- [Venture Capital Investors in Kenya](https://shizune.co/investors/venture-capital-investors-kenya)
- [Venture Capital Investors in Africa](https://shizune.co/investors/venture-capital-investors-africa)
- [Venture Capital VC Funds in Africa](https://shizune.co/investors/venture-capital-vc-funds-africa)
- [Venture Capital VC Funds in Kenya](https://shizune.co/investors/venture-capital-vc-funds-kenya)

## FAQ

### What does Wilson Sonsini Goodrich & Rosati invest in?

Wilson Sonsini Goodrich & Rosati invests primarily in Software, Biotechnology and Health Care startups, most often at Seed and Series A stage. Most of the 116 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Wilson Sonsini Goodrich & Rosati's check size?

Wilson Sonsini Goodrich & Rosati typically joins rounds of $450k–$7.3M at Seed, $1.5M–$15M at Series A and $8.5M–$55M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Wilson Sonsini Goodrich & Rosati participates in.

### How do I contact Wilson Sonsini Goodrich & Rosati?

Public channels for Wilson Sonsini Goodrich & Rosati include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Wilson Sonsini Goodrich & Rosati?

The team at Wilson Sonsini Goodrich & Rosati includes David Wanek (Law Clerk), Donald E. Bradley (General Counsel) and Douglas J. Clark (Managing Partner), among 17 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co